BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 28, 2011
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 2/25 cls
Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Needham Alan Carr Upgrade Buy (from hold) 0% $11.36
Carr upgraded based on newsflow from the company's clinical pipeline in 2011 and low valuation that is only modestly above cash. He expects final Phase I data for ALN-VSP in...

Read the full 423 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >